← Back to Analyst Consensus 
AVDL Hold
AVADEL PHARMACEUTICALS PLC
Current Price —
Implied Upside —
Analysts 16
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Nov 20, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $22.5 | 54% |
| Nov 7, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $20 | 54% |
| Oct 28, 2025 | UBS | downgrade | Buy → Neutral | $20 | 54% |
| Oct 23, 2025 | Leerink Partners | downgrade | Outperform → Market Perform | $18.5 | 50% |
| Oct 23, 2025 | HC Wainwright & Co. | downgrade | Buy → Neutral | $20 | 44% |
| Oct 22, 2025 | Jefferies | downgrade | Buy → Hold | $20 | 52% |
| Oct 22, 2025 | Needham | downgrade | Buy → Hold | $0 | 50% |
| Sep 5, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $36 | 44% |
| Sep 3, 2025 | Wells Fargo | initiate | — → Equal-Weight | $16 | 54% |
| Aug 21, 2025 | UBS | maintain | Buy → Buy | $20 | 54% |
| Aug 8, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $24 | 44% |
| May 8, 2025 | Needham | reiterate | Buy → Buy | $19 | 50% |
| Apr 9, 2025 | Needham | reiterate | Buy → Buy | $19 | 50% |
| Mar 4, 2025 | Needham | reiterate | Buy → Buy | $19 | 50% |
| Mar 4, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $21 | 44% |
| Mar 3, 2025 | Needham | reiterate | Buy → Buy | $19 | 50% |
| Feb 11, 2025 | Deutsche Bank | initiate | — → Buy | $12 | 57% |
| Jan 13, 2025 | UBS | maintain | Buy → Buy | $14 | 54% |
| Jan 10, 2025 | Piper Sandler | maintain | Overweight → Overweight | $13 | 54% |
| Jan 10, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $21 | 44% |
| Jan 9, 2025 | Needham | maintain | Buy → Buy | $19 | 50% |
| Nov 12, 2024 | Needham | reiterate | Buy → Buy | $22 | 50% |
| Oct 31, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $27 | 44% |
| Oct 31, 2024 | Oppenheimer | maintain | Outperform → Outperform | $30 | 52% |
| Oct 31, 2024 | Needham | reiterate | Buy → Buy | $22 | 50% |
| Apr 9, 2024 | Needham | reiterate | Buy → Buy | $22 | 50% |
| Mar 5, 2024 | Craig-Hallum | maintain | Buy → Buy | $22 | 54% |
| Mar 5, 2024 | Oppenheimer | maintain | Outperform → Outperform | $29 | 52% |
| Mar 5, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $25 | 44% |
| Mar 5, 2024 | Piper Sandler | maintain | Overweight → Overweight | $23 | 54% |
| Mar 5, 2024 | Needham | maintain | Buy → Buy | $22 | 50% |
| Feb 6, 2024 | UBS | initiate | — → Buy | $21 | 54% |
| Dec 20, 2023 | Needham | maintain | Buy → Buy | $20 | 50% |
| Nov 9, 2023 | Needham | maintain | Buy → Buy | $19 | 50% |
| Oct 4, 2023 | Needham | reiterate | Buy → Buy | $18 | 50% |
| Sep 25, 2023 | Needham | reiterate | Buy → Buy | $18 | 50% |
| Aug 10, 2023 | Piper Sandler | maintain | Overweight → Overweight | $18 | 54% |
| Aug 10, 2023 | Needham | reiterate | Buy → Buy | $18 | 50% |
| Aug 10, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $21 | 44% |
| Aug 9, 2023 | Needham | reiterate | — → Buy | $18 | 50% |
| Jul 5, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $21 | 44% |
| Jun 30, 2023 | Oppenheimer | maintain | Outperform → Market Outperform | $25 | 52% |
| Jun 30, 2023 | Needham | reiterate | Buy → Buy | $18 | 50% |
| Jun 12, 2023 | Oppenheimer | reiterate | Outperform → Outperform | $22 | 52% |
| May 30, 2023 | Needham | reiterate | — → Buy | $18 | 50% |
| May 2, 2023 | LifeSci Capital | maintain | — → Outperform | $26 | 55% |
| May 2, 2023 | Ladenburg Thalmann | maintain | — → Buy | $16 | 45% |
| May 2, 2023 | Oppenheimer | maintain | — → Outperform | $22 | 52% |
| May 2, 2023 | HC Wainwright & Co. | maintain | — → Buy | $17.5 | 44% |
| May 2, 2023 | Needham | maintain | — → Buy | $14 | 50% |
Cross-Platform Signals
No cross-platform signals in the last 90 days